Navigation

TA86 Gastrointestinal stromal tumours - imatinib: information for the public

Some advice on using imatinib for the treatment of unresectable and/or metastatic gastrointestinal stromal tumours has been replaced by TA209 Gastrointestinal stromal tumours (unresectable/metastatic) - imatinib.  See the guidance and the understanding NICE guidance document for more details.

This page was last updated: 30 December 2010

Accessibility | Cymraeg | Freedom of information | Vision Impaired | Contact Us | Glossary | Data protection | Copyright | Disclaimer | Terms and conditions

Copyright 2014 National Institute for Health and Care Excellence. All rights reserved.

Selected, reliable information for health and social care in one place

Accessibility | Cymraeg | Freedom of information | Vision Impaired | Contact Us | Glossary | Data protection | Copyright | Disclaimer | Terms and conditions

Copyright 2014 National Institute for Health and Care Excellence. All rights reserved.